Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
81M
-
Shares change
-
+10.8M
-
Total reported value, excl. options
-
$1.6B
-
Value change
-
+$213M
-
Put/Call ratio
-
0.25
-
Number of buys
-
90
-
Number of sells
-
-33
-
Price
-
$19.72
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q3 2022
148 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q3 2022.
Revolution Medicines, Inc. - Common Stock (RVMD) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81M shares
of 186M outstanding shares and own 43.6% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (7.38M shares), VANGUARD GROUP INC (6.98M shares), Bellevue Group AG (4.68M shares), Column Group LLC (4.58M shares), STATE STREET CORP (4.31M shares), Nextech Invest AG (4.19M shares), BOXER CAPITAL, LLC (3.98M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.65M shares), TRV GP III, LLC (3.6M shares), and BVF INC/IL (3.26M shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.